Individual Placement and Support for Mental Illness
(IPS Trial)
Trial Summary
What is the purpose of this trial?
There is substantial data to suggest that the Individual Placement and Support (IPS) model, a the investigatorsll-known, evidence-based practice, can help people with mental illness (PSMI) succeed in competitive employment (i.e., on average 55%, but over 60% in credible studies). Hothe investigatorsver, not a single country in Latin America offers IPS services. In addition, services to support employment and education tend to be ad hoc, low-intensity, and not the investigatorsll evaluated because most clinicians are not trained in evidence-based practices. Clinicians are not trained in evidence-based approaches and do not provide high-fidelity services. The overall goal of this project is to pilot the IPS for PSMI in the Center for Comprehensive Care in Long-Stay Mental Health (CAISAME-EB, in Spanish), the largest mental health clinic in Jalisco, Mexico. CAISAME-EB integrates primary care and provides medication and psychosocial rehabilitation services to a large population of PSMI (n=\~5,000). This team serves marginalized communities similar to other urban areas in low- and middle-income countries (LMICs) in Latin America and elsewhere. The investigators will use the Dynamic Adaptation Process model to first inform the adaptation of IPS in Mexico, using our previous experience adapting IPS and deep understanding of the local context (e.g., the nature of the labor market in Mexico) to inform the adaptations. The investigators will then evaluate the implementation and impact of the adapted IPS in a pilot RCT (N = 120). This pilot RCT will Include quantitative and qualitative assessments at baseline, 6 months, and 12 months with clients, providers, and other key stakeholders. The investigators aim to refine implementation processes, understand outcomes and tools, and estimate pothe investigatorsr for a future regional trial in Latin America.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on employment support rather than medication changes.
What data supports the effectiveness of the treatment Individual Placement and Support (IPS) for mental illness?
Is Individual Placement and Support (IPS) safe for people with mental illness?
How is the Individual Placement and Support (IPS) treatment different from other treatments for mental illness?
Individual Placement and Support (IPS) is unique because it focuses on helping people with serious mental illness find and keep competitive jobs in regular work settings, emphasizing personal preferences and rapid job placement. Unlike other treatments, IPS integrates employment specialists into mental health teams and provides ongoing support tailored to each individual's needs.134511
Research Team
JESUS A. ALDANA LOPEZ, MPH
Principal Investigator
Jalisco Institute of Mental Health (SALME)
Eligibility Criteria
This trial is for adults with mental illness in Jalisco, Mexico who want paid work but haven't had a job in the last 3 months. They must be getting help from CAISAME-EB, can't use other job services during the study, and need to have been to two info sessions before joining.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Adaptation and Training
Adaptation of the IPS model and training of the IPS teams
Implementation and Evaluation
Implementation of the adapted IPS model and evaluation through a pilot RCT
Follow-up
Participants are monitored for outcomes such as employment and mental health functioning
Treatment Details
Interventions
- Individual Placement and Support (IPS)
Individual Placement and Support (IPS) is already approved in United States, European Union for the following indications:
- Serious Mental Illness
- Co-occurring Substance Use Disorders
- Veterans with Opioid Use Problems
- Serious Mental Illness
- Co-occurring Substance Use Disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente
Lead Sponsor
Instituto Jalisciense de Salud Mental (SALME)
Collaborator
Research Foundation for Mental Hygiene, Inc.
Collaborator
Columbia University
Collaborator